European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk
(Q52845873)
scientific article published on 27 October 2016
scientific article published on 27 October 2016
Language:
other details
description | scientific article published on 27 October 2016 |
External Links
(P356) |
10.1093/EURHEARTJ/EHW480
|
(P698) |
27789571
|